229 related articles for article (PubMed ID: 25636810)
1. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
2. Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.
Huang J; Xu L; Huang Q; Luo J; Liu P; Chen S; Yuan X; Lu Y; Wang P; Zhou S
J Cell Mol Med; 2015 Jul; 19(7):1672-88. PubMed ID: 25753319
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-chain acyl-CoA dehydrogenase on cardiomyocyte apoptosis.
Zeng Z; Huang Q; Shu Z; Liu P; Chen S; Pan X; Zang L; Zhou S
J Cell Mol Med; 2016 Jul; 20(7):1381-91. PubMed ID: 26989860
[TBL] [Abstract][Full Text] [Related]
4. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
5. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
7. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
[TBL] [Abstract][Full Text] [Related]
8. The role of angiopoietin-like protein 4 in phenylephrine-induced cardiomyocyte hypertrophy.
Sun Y; Li Y; Liu C; Xue R; Dong B; Huang H; Peng L; Liu J; Dong Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 29339422
[TBL] [Abstract][Full Text] [Related]
9. Flavine adenine dinucleotide inhibits pathological cardiac hypertrophy and fibrosis through activating short chain acyl-CoA dehydrogenase.
Ma Z; Qin X; Zhong X; Liao Y; Su Y; Liu X; Liu P; Lu J; Zhou S
Biochem Pharmacol; 2020 Aug; 178():114100. PubMed ID: 32540485
[TBL] [Abstract][Full Text] [Related]
10. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
11. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
12. Fish oil constituent eicosapentaenoic acid inhibits endothelin-induced cardiomyocyte hypertrophy via PPAR-α.
Shimojo N; Jesmin S; Sakai S; Maeda S; Miyauchi T; Mizutani T; Aonuma K; Kawano S
Life Sci; 2014 Nov; 118(2):173-8. PubMed ID: 24792520
[TBL] [Abstract][Full Text] [Related]
13. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
14. Riboflavin ameliorates pathological cardiac hypertrophy and fibrosis through the activation of short-chain acyl-CoA dehydrogenase.
Peng H; Xie M; Zhong X; Su Y; Qin X; Xu Q; Zhou S
Eur J Pharmacol; 2023 Sep; 954():175849. PubMed ID: 37331684
[TBL] [Abstract][Full Text] [Related]
15. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
[TBL] [Abstract][Full Text] [Related]
17. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome Proliferator-Activated Receptor
Jen HL; Liu PL; Chen YH; Yin WH; Chen JW; Lin SJ
Mediators Inflamm; 2016; 2016():5609121. PubMed ID: 27807394
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta.
Smeets PJ; Teunissen BE; Planavila A; de Vogel-van den Bosch H; Willemsen PH; van der Vusse GJ; van Bilsen M
J Biol Chem; 2008 Oct; 283(43):29109-18. PubMed ID: 18701451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
